Compare SLRX & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLRX | FICO |
|---|---|---|
| Founded | N/A | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 41.2B |
| IPO Year | N/A | 1987 |
| Metric | SLRX | FICO |
|---|---|---|
| Price | $0.79 | $1,817.17 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $2,050.69 |
| AVG Volume (30 Days) | ★ 664.7K | 171.1K |
| Earning Date | 11-14-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.78 |
| EPS | N/A | ★ 26.54 |
| Revenue | N/A | ★ $1,990,869,000.00 |
| Revenue This Year | N/A | $24.77 |
| Revenue Next Year | N/A | $17.55 |
| P/E Ratio | ★ N/A | $69.52 |
| Revenue Growth | N/A | ★ 15.91 |
| 52 Week Low | $0.71 | $1,300.00 |
| 52 Week High | $108.00 | $2,217.60 |
| Indicator | SLRX | FICO |
|---|---|---|
| Relative Strength Index (RSI) | 26.49 | 58.01 |
| Support Level | $0.81 | $1,724.43 |
| Resistance Level | $0.89 | $1,858.91 |
| Average True Range (ATR) | 0.07 | 46.74 |
| MACD | 0.10 | 0.73 |
| Stochastic Oscillator | 8.25 | 68.72 |
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.